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Multinucleate cells, i.e., multiple nuclei share one 
common cytoplasm, are frequently observed in various 
patho-physiological conditions, including development, 
aging, inflammation and malignant tumor. Multi-
nucleate cells can be induced by the fusion of multiple 
cells or formed by nuclear division that is not followed 
by cytokinesis [1]. During inflammation, such as 
infection from tuberculosis, herpes, HIV, or foreign 
bodies, macrophages can be multinucleated [2]. 
Inflammation-induced microglia multinucleation is 
known to be due to cytokinesis failure [3]. Age-related 
multinucleate cells have been observed in various 
tissues and cells, such as vascular endothelial cells [4] 
and retinal pigment epithelial (RPE) cells [5].  
 
The appearance of binuclear and multinuclear RPE cells 
in mice and humans are mostly  reported  in  ageing  and  
 
 
disease conditions such as age-related macular 
degeneration (AMD). Ts’o and Friedman’s landmark 
studies in the late 1960’s noted a variable increase in 
RPE cell size as well as multinucleation with age in 
humans [5]. Al-Hussaini et al further reported 
multinucleate RPE cells in proximity to drusen and they 
are greater in number in AMD compared to age 
matched healthy controls [6]. In rodents, binucleation is 
a late developmental event with 2% of cell binucleated 
at P1 and 26% by P30 in mouse [7]. We reported an 
age-dependent increase in the number and size of 
multinucleate RPE cells in mice [8]. However, the 
underlying mechanism related to age-induced multi-
nucleation of RPE cells remains poorly defined. There 
is much debate on the mitotic ability of RPE cells. Del 
Priore [9] showed that there is little evidence for overall 
cell loss in the human RPE with age [9] and Al Hussaini 
[10] observed few dividing RPE in rats with BrdU. 




















Retinal pigment epithelial  (RPE)  cells  increase  in  size and multinucleate during aging. We have  shown using
human and mouse cell lines that oxidised photoreceptor outer segments (oxPOS)‐induced cytokinesis failure is
related  to  RPE  cell  multinucleation,  although  the  underlying  mechanism  remains  unknown.  This  study
investigated  the  role  of  the  PKC  pathway  in  oxPOS‐induced RPE multinucleation  using ARPE19  cells.  oxPOS




multinucleation. Our results suggest that oxPOS‐induced ARPE19 cytokinesis failure  is, at  least  in part, due to
the upregulation of p27kip1 through activating the PKC, particularly PKCζ pathway. Targeting the PKCζ‐p27kip1
signalling axis may be a novel approach to restore RPE repair capacity during aging. 
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Whereas other studies show RPE cells decline in 
numbers with increasing age [8,11]. 
 
Phagocytosis of photoreceptor outer segments (POS) is 
essential for visual function. In our previous study, we 
have shown that multinucleation of RPE is due to 
cytokinesis failure mediated by POS, particularly the 
oxidized POS (oxPOS), through generation of reactive 
oxygen species (ROS) [8]. ROS are known to play an 
important role in several signalling pathways and 
cellular functions [12]. They have been implicated, for 
example, in the activation of different Protein Kinase C 
(PKC) isoforms [13]. Our system represents a model of 
oxidative insult-induced cell multinucleation under 
aging conditions.  
 
PKC plays a crucial role in key cellular processes, 
including proliferation, differentiation, and mitosis [14]. 
There are three sub-families of PKC isoforms. The 
classic PKCs (cPKC: PKCα, PKCβI, PKCβII, and 
PKCγ) require calcium, phosphatidylserine, and 
diacylglycerol (DAG) for activation. The novel PKCs 
(nPKC: PKCδ, PKCε, PKCη, PKCθ and PKCμ) do not 
require calcium for activation. The activation of atypical 
PKCs (aPKC: PKCζ, PKCι) depends on phosphatidyl-
serine, but not DAG or calcium [15]. The functional 
differences of different PKC isoforms are primarily due 
to their subcellular localisation, activation or inhibition 
by different stimuli. PKC isoform activation in RPE 
cells is well documented and has been shown to impact 
RPE cell migration, melanin synthesis and phagocytosis 
[16, 17]. Activation of PKCα isoform is known to be 
related to RPE proliferation and inhibition of PKCα has 
been considered as a potential therapeutic option for 
proliferative vitreoretinopathies (PVR) [18]. 
 
In this study, we investigated the role of the PKC 
pathway in oxPOS-induced RPE multinucleation. Our 
results demonstrate that oxPOS increases PKC mRNA 
expression and PKC activity in human RPE cells. 
Importantly, we show that blockade of PKC activity, 
particularly the PKCζ isoform of the atypical PKC 





oxPOS activates PKC and PKC activation is 
involved in RPE multinucleation 
 
Western blot showed that PKC proteins are constitutive-
ly expressed in ARPE19 cells (Fig. 1A). PMA, a PKC 
activator, and POS or oxPOS did not affect the 
expression of total PKC protein (Fig. 1A-1C), although 
the expression was suppressed by a cocktail of PKC 
isoform inhibitors (Fig. 1A, 1B). Interestingly, the PKC 
kinase activity was significantly enhanced by PMA 
(100 nM, Fig. 1D) and oxPOS in a concentration-
dependent manner (Fig. 1E). Both PMA and oxPOS 
increased the percentage of multinucleate ARPE19 cells 
from 7% (under non-stimulatory conditions) to 
approximately 33%, an effect that was abolished by the 
PKC inhibitor cocktail (Fig. 1F-J). Comparable results 
were observed when the experiment was performed in 
human RPE cells derived from primary culture (Fig. 
S1). Our results suggest that PKC activation can induce 
RPE multinucleation. 
 
PKC isoform expression in POS and oxPOS treated 
ARPE19 cells 
 
To understand which isoforms of PKC may be involved 
in oxPOS mediated RPE multinucleation, we examined 
the expression profile of different PKCs in ARPE19 
cells. Of the 11 PKC isoforms from the three PKC sub-
families, mRNAs for PKCα β1, δ, ε, ζ, η, ι, and μ 
isoforms were detected in ARPE19 cells (Fig. 2A). The 
other isoforms including PKC βII, γ and θ were not 
detected (Fig. S2), though they were detected in positive 
controls (human serum cDNA, data not shown). The 
treatment of ARPE19 cells with oxPOS significantly 
upregulated the expression of PKC α, δ, ζ, ι and μ 
compared to untreated controls (Fig. 2B), whereas POS 
treatment only enhanced the expression of PKC μ (Fig. 
2B). Immunocytochemistry further confirmed the 
expression of PKC α, δ, ζ, ι and μ isoforms in ARPE19 
cells under control, POS and oxPOS treated conditions 
(Fig. 2C). 
 
The role of PKCα in oxPOS-mediated RPE 
multinucleation 
 
PKCα is constitutively expressed by RPE cells at high 
levels (Fig. 2A, S2). PKCα belongs to the classic PKC 
family and its activation is calcium dependent, whereas 
the novel and the atypical family isoforms are calcium 
independent [19]. Intracellular calcium labelling using 
Fluo-4 revealed intense fluorescence in control 
untreated and oxPOS-treated ARPE19 cells (Fig.. S3A, 
S3B). The treatment with BAPTA-AM (a Ca2+ 
selective chelator) significantly reduced Fluo-4 staining 
in oxPOS-treated cells and almost completed abolished 
the staining in untreated control cells (Fig. S3), 
suggesting that BAPTA-AM satisfactory blocked 
intracellular calcium in ARPE19 cells. Chelation of 
intracellular Ca2+ using BAPTA-AM 48h before 
oxPOS treatment led to a 33% reduction in the number 
of multinucleate cells (Fig. 3A-D). Similar effects were 
observed following treatment of the cells with a PKCα 
inhibitor (Fig. 3E-F). The results suggest that PKCα is 
partially responsible for oxPOS-induced ARPE19 
multinucleation. 


















































































































blots  showing  total  PKC  protein  expression  in  RPE  cells  following  PMA,  total  PKC  blockade,  no  treatment  and  with  different
concentrations  of  POS  or  oxPOS  treatments  (RPE:  POS/oxPOS  1:2,  1:5,  1:10)  for  48h.  (B‐C)  quantification  of  total  PKC  expression  in
different treatment groups. The data are represented as relative fold change to the control. (D) Active PKC  levels  in RPE cells following
PMA,  total PKC blockade  treatments, or untreated  control  for 48h.  (E) Active PKC protein  levels  in RPE  cells  following POS or oxPOS
treatment  at  1:10  and  1:2  (RPE:  POS/oxPOS)  for  48h.  Cells  from  each  treatment  group was  homogenised  and  protein  levels were
evaluated by active PKC ELISA kit. *, P < 0.05; ***, P < 0.001 compared  to  the control untreated group. One‐way ANOVA  followed by
Dunnett’s multiple  comparison  test. N  =  3.  (F‐I):  histochemical  staining  of  propidium  iodide  (PI)  and  Phalloidin  in  control  untreated
ARPE19  (F), PMA  treated ARPE19  (G), PKC blocked ARPE19  (H) and oxPOS  (I)  treated ARPE19 cells. Arrows  indicate multinucleate RPE
cells. (J) histogram showing the percentage of binucleated and multinucleate RPE cells, ***, P < 0.001 compared to control untreated.
One‐way ANOVA followed by Dunnett’s multiple comparison test. 50 cells were counted from three wells for each group. 
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The role of PKC δ, ζ, ι and μ in oxPOS-induced RPE 
multinucleation 
 
To further explore the role of different PKC isoforms on 
oxPOS-induced RPE cell multinucleation, the activities 
of other isoforms including PKC δ/ε, ζ, and ι that 
showed significant upregulation upon oxPOS treatment 
were blocked using specific inhibitors. PKCι inhibition 
resulted in 18% reduction in multinucleate cells 
(P<0.05, Fig. 4A, 4F). Interestingly, PKCζ blockade 
resulted in 50% reduction in multinucleate cells (Fig. 
4B, 4F). Inhibition of PKC δ/ε isoforms did not 
significantly affect oxPOS-induced ARPE19 cell 
multinucleation (Fig. 4C, 4F). Our results suggest that 
PKCζ, a member of the atypical PKC subfamily, plays 









































PKC ζ-dependent expression of p27kip1 in ARPE19 
cells 
 
PKC activity has been positively associated with 
phosphorylation of cell cycle regulatory molecules 
including Cdk inhibitory proteins p21 WAF1 and 
p27kip1. To further understand the underlying 
mechanism related to PKC mediated RPE 
multinucleation, we examined p21 WAF1 and p27kip1 
expression in ARPE19 cells. A significant increase in 
p27kip1 protein expression was observed in oxPOS-
treated group as well as the PMA-treated group (Fig. 
5A), although the expression of p21 WAF1 was not 
affected by POS or oxPOS treatment (Fig. S4). The 
upregulation of p27kip1 in oxPOS treated ARPE19 
cells was significantly reduced by PKCζ inhibitor (Fig. 



















































































(Fig. 5B, 5C). These results suggest that the 
upregulation of p27kip1 following oxPOS treatment 
depends on PKCζ activation. 
 
Immunocytochemistry revealed strong p27kip1 
expression in both the nucleus and cytoplasm in oxPOS 
treated ARPE19 cells (Fig. 5D), whereas only weak 
p27kip1 expression was detected in untreated ARPE19 
cells (Fig. 5E). 
 
The role of p27kip1 in RPE cell multinucleation 
 
To further confirm the role of PKCζ - p27kip1pathway 
in oxPOS-induced RPE multinucleation, a p27kip1 
transcriptional inhibitor, Alsterpaullone, 2-Cyanoethyl 
(A2CE) was used. A2CE inhibits p27Kip1 transcription 
by preventing FoxO3a from binding to the p27kip1 
promoter [20]. A2CE at 1μM and 5μM did not show 
any toxicity to ARPE19 cells (data not shown). 
However, it dose-dependently suppressed p27kip1 
expression (Fig. 6A, 6B), and reduced oxPOS-induced 
ARPE19 multinucleation (Fig. 6C, 6D). Our results 
suggest that p27kip1 is critically involved in oxPOS-




Previously, we have shown that POS and oxPOS 
increased ROS production and DNA oxidation in RPE 
cells, and we postulate that oxPOS-induced DNA 
oxidation may contribute to RPE multinucleation [8]. In 
this study, we further show that oxPOS activates the 
PKC pathway, particularly PKCζ, PKCα, and PKCι, 
leading to the upregulation of p27kip1 and cell cycle 
disruption. Our data suggest that the PKCζ - p27kip1 
pathway may play a key role in oxidative stress 
mediated RPE cell multinucleation. 
 
The PKC pathway is known to be involved in different 
types of cell multinucleation. Macrophages fuse to 
become multinucleate giant cells during chronic 
inflammation [21]. Cytokines such as IL-4, IL-13, IL-3, 
IL-17A, and interferon (IFN)-γ have been shown to 
induce macrophage multinucleation [22, 23]. The PKC 
pathways in particular PKCα, PKCβ, and PKCδ are 
known to be involved in IL-4-induced macrophage 
multinucleation [24, 25]. PKCs are also known to be 
involved microglia multinucleation under inflammatory 
conditions [3]. Various PKCs are known to be activated 
in microglia by Lipopolysaccharide (LPS), Amyloid 
beta (Aβ) and INF-γ [3]. Hornik and colleagues 
demonstrated that the PKC activator PMA increased 
microglial multinucleation whereas the PKC inhibitor 
Gӧ6976, which specifically inhibits PKCs α, β and ɩ, 
prevented LPS and Aβ-induced multinucleation. PMA 
has been shown to induce multinucleation of 
mesenchymal stem cells through inhibition of 
cytokinesis [26]. 
 
The role of ROS in the activation of PKCs is well 
established [27, 28]. In the current study, the level of 
active PKC was increased following oxPOS but not 
POS treatment. Interestingly, the treatment did not 
affect the total PKC protein levels although the mRNA 
expressions of some isoforms such as PKCα, PKCδ, 
PKCζ, PKCι and PKCμ were upregulated. When using 
specific inhibitors, the greatest suppression of 
multinucleate ARPE19 was observed when PKCζ was 
inhibited, followed by PKCα and PKCι inhibition, 
suggesting that these isoforms are involved in oxPOS-
induced RPE multinucleation. The PKC proteins consist 
of two pairs of zinc finger structures within the 
regulatory domain and these are the sites of 
diacylglycerol (DAG) and phorbol ester binding. Each 
Figure  2.  Expression  of  PKC  isoforms  in ARPE19  cells.  (C)
Immunofluorescent  staining of PKCα, PKCδ, PKCζ, PKCι and PKCμ
isoforms  in  RPE  cells  following  POS  or  oxPOS  treatments.  The
isoforms were in green, nuclei were labelled by PI in red. 
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zinc finger is formed by a structure that consists of six 
cysteine residues and two zinc atoms [29], and the 
structure can be destroyed by oxidants, resulting in the 
catalytic activation of PKC in the absence of Ca2+ or 
phospholipids [30]. Oxidants can also modify the C-
terminus of the catalytic domain leading to inactivation 
of PKC. This effect of oxidants and the resulting 
signalling mechanism vary in different isoforms and 
cell types [31]. We found that when Ca2+ is chelated 
the oxPOS-induced RPE multinucleation was only 
reduced by 30%, suggesting that oxPOS-mediated ROS 
may also act on the regulatory domain of the PKC and 
result in continuous PKC activity in the absence of 
Ca2+. 
 
PKCs play important roles in cell cycle regulation. PKC 
regulates cell cycle both in G1/S and in G2/M stages 
through the modulation of CDK activity [32]. However, 
the precise role of different isoforms of PKC in the 
control of cell cycle and the complex intracellular 
networks involved are poorly explored. A previous 


































inhibitory role in cell cycle progression in intestinal 
epithelial cells [33]. The authors demonstrated that 
treatment of IEC-18 cells with a panel of PKC agonists 
resulted in G1 arrest and delayed transition through the 
S and G2/M phases through upregulation of p21 and 
p27, which then lead to hypophosphorylation of 
retinoblastoma protein [33]. Here, we show that PKCζ 
activation plays an important role in oxPOS-induced 
cytokinesis failure and multinucleation in RPE cells 
through upregulating p27kip1 expression. Our study is 
the first to demonstrate that the activation of PKCζ 
exerts effects on the p27kip1 to induce cell 
multinucleation. 
 
The p27kip1 is known to be part of a cell-intrinsic 
regulator that arrests cell cycle and initiates 
differentiation [34]. Our findings mirror those reported 
in previous studies investigating PKC-induced 
upregulation of p27 in other cell types [35, 36], 
although in different down-stream pathways. A 
previous study has shown that PKCα mediated down-

































































































































































inhibitor  treated  RPE  cells  showing  p27kip1  at  28  KDa
and  β‐actin  at  40  KDa.  (C)  quantification  of  p27kip1




oxPOS  treated  group.  One‐way  ANOVA  followed  by
Tukey’s multiple  comparison  test.  N  =  3.  (D)  ARPE‐19
cells were stained for p27kip1 (green) and PI (red) after
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whereas p27kip1 up-regulation resulted in suppressed 
RPE proliferation [18]. Other studies have shown that 
p27kip1 knockout led to increased capacity of RPE to 
proliferate [37, 38]. Kokkinopoulos and colleagues 
found that the p27kip1 was significantly elevated in 
mouse RPE cells from the central regions of the eye-cup 
in comparison to cells from the periphery [39]. This 
geographic-specific upregulation of p27kip1 is in line 
with the distribution of bi-/multi-nucleate RPE cells in 
adult/aged mice [8] and aged human eyes [40]. Yoshida 
and colleagues [38] demonstrated up-regulation of 
p27kip1 expression when RPE was detached from the 
retina. Furthermore, Defoe and colleagues [37] found 
that the average size of individual RPE cells was 
significantly smaller in p27kip1 null mice, compared to 
wild-type litter mates. These data suggest that p27kip1 
is an important regulator of cell proliferation at least in 






































p27kip1 was implicated in RPE cell multinucleation, a 
concept already evidenced in other cell types including 
myogenic cells and osteoclasts [41, 42]. 
 
RPE has been considered as a post-mitotic cell and RPE 
senescent and dysfunction underlines many age-related 
retinal degenerative diseases including AMD [43]. We 
argue that RPE nuclei are capable of duplication in 
response to stimuli in vivo. However, the full cycle of 
cell division cannot be completed due to oxPOS 
mediated cytokinesis failure [8]. This study uncovered a 
novel signalling pathway related to oxidative insult-
mediated cell multinucleation highlighting the roles of 
PKCs, in particular PKCζ isoform and Cdk inhibitor 
p27kip1 (Fig. S5). PKC activation not only is associated 
with fusion (macrophage) and inflammation-induced 
(microglia) cell multinucleation, but also functions as 







































Figure 6.  Inhibition of p27kip1 using Alsterpaullone, 2‐Cyanoethyl  (A2CE) and  its effect on RPE multinucleation.  (A)
representative western blot from oxPOS, control, 5μM A2CE and 1μM A2CE treated RPE cells showing p27kip1 at 28 KDa and β‐actin
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Further understanding the molecular mechanism related 
to oxPOS-induced PKC-p27kip1 activation may 
uncover novel targets to normalize RPE cell cycle and 
promote in vivo cellular repair. This could represent a 
novel approach to prevent or treat RPE dysfunction 
during retinal degenerative diseases such as AMD. 
ROS-mediated cell cycle disruption and cytokinesis 
failure may also be responsible for the multinucleation 
of other cells under aging or inflammatory conditions. 
The role of the PKC-p27 kip1 pathway in various age-
related cell multinucleation warrants further invest-
tigation. 
 
MATERIALS AND METHODS 
 
In vitro RPE cell culture 
 
Human ARPE19 cells were purchased from ATCC 
(CRL-2302, Middlesex, UK). Primary human RPE cells 
were cultured from a donor eye (free of known eye 
diseases) obtained from the Manchester Eye Bank using 
the protocol described previously [44]. Briefly, after the 
removal of vitreous and retina, the eye cup was washed 
with Hanks’ balanced salt solution (HBSS), and filled 
with 0.25% (v/v) trypsin (ThermoFisher, Hemel 
Hempstead, UK) for 2h at 37°C. Cells were then 
removed from the basement membrane by gentle 
aspiration. The cells were washed twice in Dulbecco’s 
Modification of Eagle’s Medium F12 (DMEM F12, 
GIBCO BRL, Paisley, UK). Both ARPE19 cell and 
primary human RPE cells were cultured in complete 
DMEM F12 medium containing 10% fetal calf serum 
(FCS) and 100 μg/mL Primocin (Invitrogen, San Diego, 
California, USA). Cells were maintained at 37°C with 
5% CO2. The phenotype of RPE cells were confirmed 
by pan-cytokeratin staining. The use of donated human 
eye tissue was approved by local Research Ethics 
Committee. During all cell culture experiments, the 
RPE cell line used were maintained between passages 3 
to 10 to ensure that RPE cell morphology had not 
changed or transdifferentiated. When inducing multi-
nucleate RPE cells, cell confluency was maintained at 
approximately 70% to ensure sufficient number of 
proliferating cells. This also facilitates identifying 
individual multinucleate cells in culture and omitting 
false-positive of overlapping cells.  
 
Preparation of photoreceptor outer segments 
 
POS were isolated from bovine eyes using method 
described previously [45]. Briefly, 10 bovine retinas 
were placed in 10 ml homogenising solution (20% w/v 
sucrose, 20 mM Tris acetate, pH 7.2, 2 mM MgCl2, 10 
mM glucose and 5 mM taurine). The suspension was 
shaken gently for 1min and then filtered through a 100 
mm cell strainer (BD, Oxford, UK) to remove tissue 
debris. The suspension was layered on 25~60% w/v 
continuous sucrose gradients containing 20 mM Tris 
acetate pH 7.2, 10 mM glucose and 5 mM taurine and 
centrifuged at 25,000 rpm for 45min at 4ºC. The pink 
band containing the POS was collected and washed with 
storage buffer (10 mM sodium phosphate, pH 7.2, 0.1 
M NaCl and 2.5% sucrose). For storage, isolated POS 
aliquots were stored at -80ºC at a concentration of 108 
POS/ml. The oxidized POS (oxPOS) were generated by 
exposing POS to 302-nm ultraviolet light (Ultraviolet 
Products, Cambridge, UK) in a laminar air-flow box for 
12h [45].  
 
In vitro generation of multinucleate RPE cells 
 
Multinucleate RPE cells were generated by incubating 
the cells with POS or oxPOS as previous described [8]. 
In brief, ARPE19 and human RPE cells were seeded at 
a density of 3000 cells per well in 12-well plates and 
incubated for 5h. The cells were then treated with POS 
or oxPOS for 48h (RPE: POS = 1:5). 
 
PKC inhibitor experiments 
 
ARPE19 cells incubated with/without oxPOS were 
treated with PKC inhibitors (Gö 6983, inhibitor of 
PKCζ at IC50 = 60 nM; Gö 6976, inhibitor of PKCα at 
IC50 = 10 nM; Aurothiomalate (ATM), inhibitor of 
PKCε at IC50 = 132 nM; Bisindolylmaleimide I, 
inhibitor of PKCι at IC50 = 1μM as recommended by 
manufacturer) for 1h followed by further 48h incubation 
with POS or oxPOS (RPE: POS = 1:5). The inhibitors 
were purchased from either Sigma Aldrich, Cheshire, 
UK (Gö 6983, Gö 6976, Bisindolylmaleimide I) or 
Cambridge Bioscience, Cambridge, UK (ATM). 
 
Calcium chelator studies 
 
ARPE19 cells were treated with the 10 μM intracellular 
Ca2+ chelator BAPTA-AM (ThermoFisher, Hemel 
Hempstead, UK) for 30 min at 37°C. The cells were 
washed and incubated with POS or oxPOS for 48h. 
Intracellular Ca2+ staining was performed by 
incubating cells with 5μM Flou-4 (ThermoFisher, 
Hemel Hempstead, UK) for 60min at 37°C. The cells 
were washed thoroughly before imaging with confocal 
microscope (Eclipse TE2000-U, Nikon, Surrey, UK) at 




RPE cells were lysed in RIPA buffer with protease 
inhibitors (Sigma-Aldrich, UK). The protein 
concentrations were measured using a BCA protein 
assay kit (PIERCE, Cramlington, UK). 20μg of the total 
protein was loaded into 10% SDS-PAGE gel. Gels were 
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run at 80V for 30 min followed by 150V for 60min. 
Proteins were transferred to the Immobilon-FL 
polyvinylidene difluoride (PVDF) membrane 
(Millipore, Watford, UK) at 350 mA for 50 min. The 
membranes were blocked with 5% bovine serum 
albumin (BSA) in tris-buffer saline with tween 20 
(TBS/T) for 1h at room temperature, followed by 
incubation with primary antibodies at 1:1000 dilutions 
at 4 °C overnight. After thorough washes, the 
membranes were incubated with secondary antibodies at 
1:5000 dilutions for 2h in dark at room temperature. 
The following primary antibodies were used for western 
blot experiments: PKC (1:1000; Cell Signaling), 
p27kip1 (1:1000; Life Technologies), p21 (1:1000; Life 
Technologies), β-actin (1:1000; Santa Cruz). The 
secondary antibodies used were: Goat anti-rabbit IRDye 
680 (1:5000), Goat anti-rabbit IRDye 800 (1:5000), 
Goat anti-mouse IRDye 680 (1:5000), Goat anti-mouse 
IRDye 800 (1:5000); (LI-COR; Lincoln). 
 
The membrane was then washed in TBS/T 3 times 
before scanning using Odyssey infrared imaging system 
(Li-COR Biotechnology, Cambridge, UK). Quantitative 

































PKC kinase activity assay 
 
Active PKC levels in ARPE19 cells were measured 
using a commercially available kit (ab139437, Abcam, 
Cambridge, UK) in accordance with the manufacturer's 
instructions. Briefly, 30μg/30μL protein of each sample 
was added to an active PKC capturing antibody coated 
96-well plate (Abcam) which was then incubated at 
30ºC for 90min. 40μL of the phosphospecific substrate 
antibody was added to each well. After a single wash, 
40μL of diluted anti-rabbit IgG: HRP conjugate was 
added to each well and incubated at room temperature 
for 30 min. Following another single wash, 60μL TMB 
substrate was added to each well and left for 30min. 
The assay was terminated by addition of 20μL stop 
buffer and absorbance measured immediately at 450nm 
using a microplate reader (BMG Labtech, Ortenberg, 
Germany). 
 
Real-time polymerase chain reaction (real-time RT-
PCR) 
 
Total RNA was extracted from RPE cells using Tri 
Reagent (Sigma-Aldrich, Cheshire, UK). The quantity 


































Family Subtype Primer 




cPKC PKCα   Forward 5’CGACTGTCTGTAGAAATCTGG3’ 327 
  Reverse 5’CACCATGGTGCACTCCACGTC3’  
 PKCβI Forward 5’TTGTGATGGAGTATGTGAACGGG3’ 404 
  Reverse 5’CCTGGGTGTTTGGTCATTAGCC3’  
 PKCβII Forward 5’GACCGGTTTTTCACCCGCCA3’ 409 
  Reverse 5’GGCATTTTCTCTCCCCATTGG3’  
 PKCγ Forward 5’TTGATGGGGAAGATGAGGAGG3’ 233 










 PKCε Forward 5’AGCTTGAAGCCCACAGCCTG3’ 249 
  Reverse 5’CTTGTGGCCGTTGACCTGATG3’  
 PKCη Forward 5’CCATGAAGATGCCAGAGGGATC3’ 239 
  Reverse 5’TCATCAATCGGAGTTAAGACGGG3’  
 PKCθ Forward 5’CTATCAATAGCCGAGAAACCATG3’ 250 









  Reverse 5’GCAGAAAGTGCTCGTTGTGTCAC3’  
 PKCι Forward 5’TATAATCCTTCAAGTCATG3’ 206 






Forward 5’CATTGGCGAGAAGTCTTTCCG3’  
 
134 
  Reverse 5’TCAGGCTCACATAGATGATGACCC3’  
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ND-1000 spectrophotometer (NanoDrop Technologies, 
Wilmington, DE). cDNA synthesis was performed in a 
reaction of 0.5-2.5μg of total RNA with a random 
primer using the SuperScript™ II Reverse Transcriptase 
kit (Invitrogen, Paisley, UK). Real-time RT-PCR was 
performed in 384-well plates using the LightCycler 480 
system (Roche Applied Science, Mannheim, Germany). 
The reaction mixture contained 6μL of LightCycler 480 
SYBR Green Master (Roche Diagnostics GmbH, 
Mannheim, Germany), 0.5μM primers and diluted 
cDNA to make a total volume of 12 μL. The primers 
used were purchased from Integrated DNA 
Technologies UK, Ltd and are listed in (Table 1). Real-
time RT-PCR quantifications were run in triplicates for 
each sample. PCR products were quantified by the 
LightCycler 480 software. Expression levels were 
normalised to 18S. Gene fold changes of treated group 
against untreated control group were calculated by 
dividing the gene expression levels of treated samples by 
control samples. PCR products were electrophoresed on 




ARPE19 and human RPE cells derived from primary 































POS or oxPOS for 48h. Cells on cover slips were 
washed with cold PBS and fixed with 1% para-
formaldehyde (PFA) for 10 min, followed by 
permeabilisation with 0.1% Triton-X for 5 min. The 
samples were then blocked with 5% BSA for 30 min at 
room temperature. Cells were incubated with the 
desired primary antibody for 4h at 1:100 dilution. After 
washing with PBS, samples were incubated with the 
desired secondary antibody at 1:100 dilution and 
counter stained for Phalloidin (1:100, Sigma Aldrich, 
Cheshire, UK) and/or PI (Vector Laboratories, 
Peterborough, UK) in the dark for 1h. After extensive 
washing, samples were mounted with mounting 
medium (Vector Laboratories, Peterborough, UK), and 
examined by confocal microscopy Eclipse TE2000-U, 
Nikon, Surrey, UK) at 40X magnification, numerical 
aperture 0.65. Primary and secondary antibodies used in 
the study are listed in (Table 2). 
 
Data and statistical analysis 
 
Data were expressed as mean ± SEM with P<0.05 
deemed statistically significant. Differences between 
groups were assessed using either an independent t test 
or one-way analysis of variance with Dunnett’s or 




































p27kip1                               1:100            Rabbit   Life technologies 
PKCα        1:100            Rabbit     Cell signalling 
PKCι    1:100            Rabbit                   Abcam 
PKCζ 1:100            Rabbit Abcam 
PKCμ   1:100 Mouse Abcam 
PKCε 1:100 Rabbit Abcam 
    
2nd antibodies    
Anti-rabbit 488 1:100 Goat Life technologies 
Anti-mouse 488 1:100 Goat Life technologies 
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Abbreviations 
 
AMD: age-related macular degeneration; A2CE:          
alsterpaullone, 2-cyanoethyl; oxPOS: oxidised photo-
receptor outer segment; PKC: protein kinase C; POS: 
photoreceptor outer segment; PVR: proliferative 
vitreoretinopathies; RPE: retinal pigment epithelium; 
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visualised  by  Odyssey  infrared  imaging  system  and  quantified  using  ImageJ  analysis  software  (version  1.45).
Signals for control were set to one and the data are represented as relative fold change *P <0.05 compared to the
control untreated group. One‐way ANOVA followed by Dunnett’s multiple comparison test. N= 3. 
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Figure S5. Proposed mechanisms of PKCζ regulation on RPE multinucleation. 
